Online citations, reference lists, and bibliographies.
← Back to Search

Complications Of ERCP.

J. Mallery, T. Baron, J. Dominitz, J. Goldstein, W. Hirota, B. Jacobson, J. Leighton, H. Raddawi, John J Varg, J. Waring, Robert D. Fanelli, Jo Wheeler-Harbough, G. Eisen, D. Faigel
Published 2003 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Principles of management: • Early diagnosis – high index of suspicion, CT scan and contrast studies • Surgery – oversewing of perforation, relief of any biliary obstruction and drainage of collections. Duodenal diversion if late diagnosis • Consider conservative or endoscopic/percutaneous measures if: Localised perforation with no extravasation No significant fluid collections No significant retroperitoneal emphysema Stable patient
This paper references
10.1136/gut.33.8.1129
Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?
K. Binmoeller (1992)
10.1016/S0016-5107(90)71115-7
Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with use of a modified aspirating catheter.
S. Sherman (1990)
10.1016/S0016-5107(94)70204-7
Post-ERCP pancreatitis: randomized, prospective study comparing a low- and high-osmolality contrast agent.
S. Sherman (1994)
10.1053/GAST.2001.26047
Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.
J. Deviére (2001)
10.1016/S1052-5157(03)00103-X
Current management of postoperative complications and benign biliary strictures.
G. Costamagna (2003)
10.1067/MGE.2002.120324
Prospective assessment of magnetic resonance cholangiopancreatography for noninvasive imaging of the biliary tree.
A. Taylor (2002)
10.1067/MGE.2002.121342
Assessment of EUS for diagnosing, staging, and determining resectability of pancreatic cancer: a review.
Gordon C. Hunt (2002)
10.1046/j.1440-1746.1999.01798.x
Comparing the treatment outcomes of endoscopic papillary dilation and endoscopic sphincterotomy for removal of bile duct stones
Y. Ochi (1999)
10.1016/S0039-6060(99)70119-4
Classification and management of perforations complicating endoscopic sphincterotomy.
T. Howard (1999)
10.1023/B:DDAS.0000020511.98230.20
Role of Osmolality of Contrast Media in the Development of Post-ERCP Pancreatitis: A Metanalysis
S. George (2004)
10.1067/MGE.2001.111388
Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors.
R. Hintze (2001)
10.1067/MGE.2001.113381
Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study.
G. D. De Palma (2001)
10.1055/S-1999-153
Meta-analysis of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography (ERCP).
A. Harris (1999)
10.1016/S0016-5107(00)70377-4
Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis.
A. Andriulli (2000)
10.1016/S0002-9270(01)02655-7
A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis
J. Dumot (2001)
10.1016/S0016-5107(86)71921-4
Precut papillotomy via fine-needle knife papillotome: a safe and effective technique.
K. Huibregtse (1986)
10.1016/S0016-5107(98)70121-X
Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study.
S. Loperfido (1998)
10.1016/S0002-9270(00)02387-X
Complications of diagnostic and therapeutic ERCP: a prospective multicenter study.
E. Masci (2001)
10.1016/S0016-5107(04)00353-0
Prevention of post-ERCP pancreatitis: a comprehensive review.
M. Freeman (2004)
10.1016/S0002-9270(03)00045-5
Endoscopic Stent Therapy in Advanced Chronic Pancreatitis: Relationships Between Ductal Changes, Clinical Response, and Stent Patency
D. Morgan (2003)
10.1055/S-2002-23650
ERCP-related perforations: risk factors and management.
R. Enns (2002)
10.1097/00000658-196805000-00013
Endoscopic cannulation of the ampulla of Vater: a preliminary report. By William S. McCune, Paul E. Shorb, and Herbert Moscovitz, 1968.
W. S. Mccune (1988)
10.1016/S0140-6736(96)11026-6
Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones
J. Bergman (1997)
10.1007/BF01296438
Effect of somatostatin analog octreotide on human sphincter of Oddi
K. Binmoeller (2005)
10.1016/S0140-6736(96)90208-1
Prospective controlled study of endoscopic ultrasonography and endoscopic retrograde cholangiography in patients with suspected common-bileduct lithiasis
F. Prat (1996)
10.1016/S0016-5107(98)70348-7
Pure cut electrocautery current for sphincterotomy causes less post-procedure pancreatitis than blended current.
G. Elta (1998)
10.1046/J.0007-1323.2001.01842.X
Prospective randomized double‐blind placebo‐controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography‐induced pancreatitis
S. Sudhindran (2001)
10.1067/MGE.2002.122616
Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP?
T. Rabenstein (2002)
10.1055/S-2003-39659
Hemobilia in hereditary hemorrhagic telangiectasia: an unusual complication of endoscopic retrograde cholangiopancreatography.
T. Costa Macedo (2003)
10.1016/S0016-5107(03)01994-1
The role of endoscopy in the evaluation and treatment of patients with pancreaticobiliary malignancy.
T. Baron (2003)
10.1016/S0016-5107(02)70178-8
Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study.
F. Prat (2002)
10.1016/S0016-5107(02)70431-8
Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial.
A. Andriulli (2002)
Rare complications of endoscopic retrograde cholangiopancreatography: two case reports.
Kingsley Dd (2001)
10.1111/j.1572-0241.1999.999_u.x
Use of corticosteroids in the prevention of post-ERCP pancreatitis: results of a controlled prospective study
G. D. Palma (1999)
10.1055/S-2007-1005482
Needle-knife access papillotomy: an unfairly maligned technique?
J. Vandervoort (1996)
10.7326/0003-4819-125-6-199609150-00002
Piperacillin To Prevent Cholangitis after Endoscopic Retrograde Cholangiopancreatography
S. J. van den Hazel (1996)
10.1016/S0016-5107(96)70053-6
Papillary roof incision using the Erlangen-type pre-cut papillotome to achieve selective bile duct cannulation.
K. Binmoeller (1996)
10.1016/S1052-5157(03)00107-7
Adverse outcomes of endoscopic retrograde cholangiopancreatography: avoidance and management.
M. Freeman (2003)
10.1016/S0016-5107(97)80418-X
Endoscopic balloon dilation compared to sphincterotomy (EDES) for extraction of bile duct stones: Preliminary results
J. Disario (1997)
10.1067/MGE.2001.119734
Early EUS of the bile duct before endoscopic sphincterotomy for acute biliary pancreatitis.
F. Prat (2001)
10.1067/MGE.2001.114714
Endoscopic drainage of malignant hilar obstruction: is one biliary stent enough or should we work to place two?
S. Sherman (2001)
10.1016/S0016-5085(98)70031-9
Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction.
P. Tarnasky (1998)
Bipolar versus monopolar sphincterotomy: a prospective trial.
J. Siegel (1994)
10.1055/S-2001-16520
A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis.
A. Budzyńska (2001)
10.1016/S0016-5107(02)70112-0
Risk factors for complications after performance of ERCP.
J. Vandervoort (2002)
10.1016/S0016-5107(04)02169-8
Complications of ERCP: a prospective study.
M. Christensen (2004)
10.1016/S0016-5107(02)70025-4
Adverse outcomes of ERCP.
M. Freeman (2002)
10.1053/GAST.2002.34232
Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy: a prospective, randomized trial.
J. Vargo (2002)
10.1111/j.1572-0241.1998.061_c.x
Pretreatment With Methylprednisolone to Prevent Ercp-Induced Pancreatitis: A Randomized, Multicenter, Placebo-Controlled Clinical Trial
J. Dumot (1998)
10.1055/S-2002-35834
Complications of endoscopic sphincterotomy: results from a single tertiary referral center.
M. Barthet (2002)
10.1055/S-2003-42614
Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis.
E. Masci (2003)
10.1067/MGE.2001.115730
Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones.
T. Aizawa (2001)
10.1016/S0140-6736(02)09896-3
Wait-and-see policy or laparoscopic cholecystectomy after endoscopic sphincterotomy for bile-duct stones: a randomised trial
Djemila Boerma (2002)
10.1016/S0016-5107(91)70740-2
Endoscopic sphincterotomy complications and their management: an attempt at consensus.
P. Cotton (1991)
10.1056/NEJM199609263351302
Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.
G. Cavallini (1996)
10.1016/S0016-5107(95)70128-1
A comparison of nonionic versus ionic contrast media: results of a prospective, multicenter study. Midwest Pancreaticobiliary Study Group.
G. K. Johnson (1995)
10.1111/j.1572-0241.2004.30151.x
Endoscopic Balloon Dilation of the Biliary Sphincter Compared to Endoscopic Biliary Sphincterotomy for Removal of Common Bile Duct Stones During ERCP: A Metaanalysis of Randomized, Controlled Trials
T. Baron (2004)
10.1159/000201021
Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography.
J. A. Sand (1993)
10.1067/MGE.2001.117550
Risk factors for post-ERCP pancreatitis: a prospective, multicenter study.
M. Freeman (2001)
10.1067/MGE.2003.29
Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial.
M. Moretó (2003)
10.1016/S0016-5107(96)70163-3
Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy.
M. Smith (1996)
10.1016/S0016-5107(99)70441-4
Diagnosis of choledocholithiasis: EUS or magnetic resonance cholangiography? A prospective controlled study.
V. de Lédinghen (1999)
10.1016/S0016-5107(94)70206-3
Endosonographic features predictive of lymph node metastasis.
M. Catalano (1994)
10.1055/S-2000-138
Analysis of the risk factors associated with endoscopic sphincterotomy techniques: preliminary results of a prospective study, with emphasis on the reduced risk of acute pancreatitis with low-dose anticoagulation treatment.
T. Rabenstein (2000)
10.1016/S0016-5107(95)70014-5
Use of corticosteroids in the prevention of post-ERCP pancreatitis.
G. R. Weiner (1995)
10.1056/NEJM199609263351301
Complications of endoscopic biliary sphincterotomy.
M. Freeman (1996)
10.1016/S0016-5107(90)70958-3
Pancreatic stents can induce ductal changes consistent with chronic pancreatitis.
R. Kozarek (1990)
10.1016/S0016-5107(99)70281-6
Efficacy and safety of intravenous propofol sedation during routine ERCP: a prospective, controlled study.
T. Wehrmann (1999)
10.7326/0003-4819-139-7-200310070-00006
Magnetic Resonance Cholangiopancreatography
J. Romagnuolo (2003)



This paper is referenced by
10.1111/den.12013
Efficacy of endoscopic nasobiliary drainage for the prevention of post‐endoscopic retrograde cholangiopancreatography pancreatitis and cholangitis after repeated clearance of common bile duct stones: Experience from a Chinese center
J. Yang (2013)
10.3109/00365521.2014.881547
Endoscopic ultrasound in patients with normal liver blood tests and unexplained dilatation of common bile duct and or pancreatic duct
K. Oppong (2014)
10.1186/2047-783X-19-26
Risk factors for post-ERCP pancreatitis: a systematic review of clinical trials with a large sample size in the past 10 years
Jianjun Chen (2014)
10.1016/j.gie.2014.11.022
Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population.
David M. Troendle (2015)
10.1016/j.hoc.2015.04.008
Imaging and Endoscopic Approaches to Pancreatic Cancer.
M. Rosenthal (2015)
10.1159/000485557
ERCP-Related Duodenal Perforation Presenting as Pneumoscrotum
M. Khan (2018)
10.4103/AZMJ.AZMJ_22_19
Role of rectal NSAID administration time in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis
Z. Zakarya (2020)
10.1055/s-0040-1713540
Factors Associated with the Success Rate of Endoscopic Retrograde Cholangiopancreatography with Standard Technique followed by Laparoscopic Cholecystectomy in the Management of Choledocholithiasis: A Single-Center Experience
Chayanon Konsue (2020)
10.1097/MD.0000000000020412
Risk factors of stone recurrence after endoscopic retrograde cholangiopancreatography for common bile duct stones
Peng Lujian (2020)
Table 2 Aldrete Postanesthesia Scoring System
K. Souter (2014)
10.1016/S0009-739X(06)70912-5
Utilidad de la colangiografía por resonancia magnética previa a la colecistectomía en la pancreatitis aguda biliar
F. J. Morera (2006)
10.1002/jgh3.12263
Post‐endoscopic retrograde cholangiopancreatography pancreatitis in single‐stage endoscopic common bile duct stone removal
H. Saito (2020)
10.1007/978-3-319-99822-0_13
Imaging of Biliary Colic and Cholecystitis
Bordonaro Veronica (2019)
10.1053/j.gastro.2015.12.040
Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients.
J. Levenick (2016)
10.1007/978-3-319-74766-8_19
Anesthesia for ERCP
B. Goudra (2018)
10.4103/sjg.SJG_121_17
The efficacy and safety of the left lateral position for endoscopic retrograde cholangiopancreatography
Tae Young Park (2017)
Are prophylactic antibiotics indicated for endoscopic retrograde cholangiopancreatography
M. Brand (2011)
10.7196/SAJS.224
Antibiotic prophylaxis for patients undergoing elective endoscopic retrograde cholangiopancreatography. A survey of South African endoscopists and review of the literature.
M. Brand (2009)
10.1109/EHB.2015.7391451
Telemedicine — A possible quality indicator for endoscopic retrograde cholangiopancreatography?
Gheorghe G Balan (2015)
The Coming of Age of Pancreatic Endoscopy as an Endoscopic Subspecialty
José Guillermo de la Mora Levy (2016)
10.5144/0256-4947.2016.57
A scoring system for the prediction of choledocholithiasis: a prospective cohort study
B. Al-Jiffry (2016)
10.1111/apha.12992
Atrial natriuretic peptide reduces inflammation and enhances apoptosis in rat acute pancreatitis
A. C. Najenson (2018)
10.1111/den.12178
Uncommon and rarely reported adverse events of endoscopic retrograde cholangiopancreatography
D. Chavalitdhamrong (2014)
10.1308/003588414X13824511650290
Endoscopic retrograde cholangiopancreatography in the treatment of intraoperatively demonstrated choledocholithiasis
A. Lynn (2014)
10.1055/a-1149-1359
Fluid type and volume reduce risk of post-ERCP pancreatitis and length of hospital stay in high-risk patients: a secondary analysis of the INDIEH trial *
R. Talukdar (2020)
10.1055/s-0042-116144
Endoscopic versus laparoscopic treatment for choledocholithiasis: a prospective randomized controlled trial
Javier Ernesto Barreras González (2016)
10.1155/2017/9031438
Manometric Measurement of the Sphincter of Oddi in Patients with Common Bile Duct Stones: A Consecutive Study of the Han Population of China
Yadong Feng (2017)
10.1016/j.rcl.2014.05.011
Computed tomography of iatrogenic complications of upper gastrointestinal endoscopy, stenting, and intubation.
David M. Valenzuela (2014)
10.1007/s00261-015-0387-y
Clinical value of spectral CT in diagnosis of negative gallstones and common bile duct stones
Huanguo Li (2015)
10.1016/j.cgh.2017.07.038
Reappraisal of Endoscopic Papillary Balloon Dilation Versus Sphincterotomy for Choledocholithiasis-Time for a New Trial.
A. Wang (2017)
10.22037/EMERGENCY.V3I2.7352
Periampullary Diverticulum Perforation Following Endoscopic Retrograde Cholangiopancreatography (ERCP); a Case Report
Li-Wei Lin (2015)
10.1186/s12876-017-0599-4
How to select patients and timing for rectal indomethacin to prevent post-ERCP pancreatitis: a systematic review and meta-analysis
Jianhua Wan (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar